Pennsylvania-based Osage University Partners has announced the successful closing of its $100-million debut venture fund, which was created to partner with leading research universities “to license cutting-edge technologies,” particularly in therapeutics. Affiliating with universities, such as the California Institute of Technology, Columbia University, Duke University, and Yale University, allows Osage to manage the “coinvestment rights” they hold, giving it contractual access to invest in the most promising startups that license the universities’ technologies. The partnership will also enable the institutions to share in Osage’s profits to stimulate educational, research and commercialization initiatives. See Osage University Partners Press Release, February 24, 2011; FierceBiotech, February 25, 2011.